Ophthalmology

Top Story

Agreement seen between ultra-widefield, ETDRS images for grading diabetic retinopathy severity

November 13, 2018

Second Sight posts quarterly net loss

November 13, 2018
Second Sight Medical Products reported a net loss of $8.5 million, or $0.12 per share, in the third quarter of 2018 compared with a net loss of $6.7 million, or $0.12…

Zimura-Lucentis combination safe in wet AMD patients in phase 2a trial

November 13, 2018
Zimura, a complement factor C5 inhibitor, was found to be well tolerated in combination with Lucentis in a phase 2a clinical trial, Ophthotech announced in a press…

Quarterly loss decreases for ProQR

November 13, 2018
ProQR Therapeutics reported a net loss of 6 million euros, or 0.18 euros per share, in the third quarter of 2018 compared with a net loss of 10.5 million euros, or 0.42…

Santen launches Verkazia in Europe to treat VKC in children

November 13, 2018
Santen U.K. Ltd. announced the launch of Verkazia eye drops in Europe for the treatment of severe vernal keratoconjunctivitis in adolescents and children at least 4…
More Headlines »
Short Subjects

Multiloculated Ciliary Body Cysts and Lenticular Coloboma: A Rare Phenotypic Variation Associated With Persistent Fetal Vasculature

Journal of Pediatric Ophthalmology and Strabismus, Volume -2147483648
Online Only, November 5, 2018
A case of a 4 year-old boy with persistent fetal vasculature, lenticular coloboma, and a benign, multiloculated ciliary…
More »
CME COPE

Ocular Surface Diseases, Disorders, and Dysfunctions®, Volume 4, Number 2

This activity is supported by an educational grant from Shire.

Ocular surface disease (OSD) is a group of disorders commonly seen in ophthalmic practice, but it is challenging to…
More »
Resource Centers
American Academy of Ophthalmology Meeting

American Academy of Ophthalmology Meeting

Video
Meeting News

VIDEO: Oxurion introduces new clinical portfolio at OIS

November 7, 2018
More »